Development and Application of Imaging Analysis in Ocular Diseases
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Ophthalmology".
Deadline for manuscript submissions: closed (30 November 2020) | Viewed by 46528
Special Issue Editor
Interests: image-processing; image analysis; biomarkers; diabetic retinopathy; cognitive impairment; Alzheime’s Disease; multiple sclerosis; artificial intelligence; machine learning; deep learning
Special Issue Information
Dear Colleagues,
The eye is a complex organ that is capable of turning light into sight, allowing us to interpret our surroundings by working similarly to the conventional camera, which gathers, focuses, and transmits light through a lens. Various analyses relying on image-processing algorithms have been proposed to efficiently examine subtle changes in the eye to diagnose ocular diseases.
Also, numerous studies have shown that the vessels and neural layers in the eye reflect what is going on in other organs, specifically the heart and brain.
Images from the eye have become enormous troves of data for algorithm development in search of biomarkers of ocular diseases as well as systemic and neurodegenerative conditions. Recent developments show that the eye is a critical player in the development and application of image analyses to foster the adoption of artificial intelligence for the prevention and management of ocular diseases in eye care systems. This Special Issue seeks to outline studies targeting the development and application of ocular imaging and imaging analysis in eye diseases.
Dr. Delia Cabrera DeBuc
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ocular diseases
- eye
- imaging analysis
- image-processing algorithms
- biomarkers
- artificial intelligence
- machine learning
- deep learning
- segmentation
- denoising
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.